Geranylgeranyl Diphosphate Synthase Inhibitor and Proteasome Inhibitor Combination Therapy in Multiple Myeloma

被引：0
|
作者：
Haney, Staci L. [1 ]
Varney, Michelle L. [1 ]
Smith, Lynette M. [2 ]
Holstein, Sarah A. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-129244
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4417
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
    Haney, Staci L.
    Varney, Michelle L.
    Williams, Jacob T.
    Smith, Lynette M.
    Talmon, Geoffrey
    Holstein, Sarah A.
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
  • [2] Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma
    Staci L. Haney
    Michelle L. Varney
    Jacob T. Williams
    Lynette M. Smith
    Geoffrey Talmon
    Sarah A. Holstein
    Experimental Hematology & Oncology, 11
  • [3] Proteasome inhibitor therapy in multiple myeloma
    Chauhan, D
    Hideshima, T
    Mitsiades, C
    Richardson, P
    Anderson, KC
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (04) : 686 - 692
  • [4] Preclinical investigation of a potent geranylgeranyl diphosphate synthase inhibitor
    Haney, Staci L.
    Chhonker, Yashpal S.
    Varney, Michelle L.
    Talmon, Geoffrey
    Murry, Daryl J.
    Holstein, Sarah A.
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (05) : 810 - 818
  • [5] Preclinical investigation of a potent geranylgeranyl diphosphate synthase inhibitor
    Staci L. Haney
    Yashpal S. Chhonker
    Michelle L. Varney
    Geoffrey Talmon
    Daryl J. Murry
    Sarah A. Holstein
    Investigational New Drugs, 2018, 36 : 810 - 818
  • [6] Preclinical Investigation of a Potent Geranylgeranyl Diphosphate Synthase Inhibitor
    Haney, Staci L.
    Chhonker, Yashpal S.
    Varney, Michelle L.
    Talmon, Geoffrey A.
    Murry, Daryl J.
    Holstein, Sarah A.
    BLOOD, 2017, 130
  • [7] Potent Triazole Bisphosphonate Inhibitor of Geranylgeranyl Diphosphate Synthase
    Wills, Veronica S.
    Allen, Cheryl
    Holstein, Sarah A.
    Wiemer, David F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (12): : 1195 - 1198
  • [8] Novel combination therapy for treating proteasome inhibitor-resistant multiple myeloma
    Kim, Byung-Gyu
    Choi, Sung Hee
    Huong Nguyen
    Liang, Fu-Sen
    Kim, Seong-Jin
    Letterio, John
    Huang, Alex
    CANCER RESEARCH, 2024, 84 (06)
  • [9] The combination of the MTOR inhibitor rapamycin and proteasome inhibitor bortezomib is synergistic in vitro in multiple myeloma
    Leleu, X.
    O'Sullivan, G.
    Jia, X.
    Ngo, H.
    Moreau, A. S.
    Roccaro, A.
    Hatjiharisi, F.
    Hideshima, T.
    Anderson, K.
    Ghobrial, I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 148 - 149
  • [10] An oral proteasome inhibitor for multiple myeloma
    Pratt, Guy
    LANCET ONCOLOGY, 2014, 15 (13): : 1417 - 1418
12345